Communiqués Instadose Pharma Corp.

Actions

INSD

US45783B1035

Marché Fermé - OTC Markets Autres places de cotation 21:34:47 29/12/2023			Varia. 5j.	Varia. 1 janv.
0,000001 ^USD	-.--%		-.--%	-.--%

2023	TetraPharma Royalty Corp. a acquis TetraPharma (Canada) Ltd. auprès d'Instadose Pharma Corp. (OTCPK:INSD).	CI
2022	Instadose Pharma Corp. annonce des changements au conseil d'administration	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

INSTADOSE PHARMA CORP. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	07/11/22	AQ
INSTADOSE PHARMA CORP. : Non-Reliance on Previous Financials, Audits or Interim Review, Financial Statements and Exhibits (form 8-K)	04/11/22	AQ
INSTADOSE PHARMA CORP. : Financial Statements and Exhibits (form 8-K)	28/09/22	AQ
INSTADOSE PHARMA CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	09/05/22	AQ
INSTADOSE PHARMA CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	15/03/22	AQ
INSTADOSE PHARMA CORP. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	23/02/22	AQ
Investor Notice: Feb 28th Deadline for certain Investors in Instadose Pharma Corp. shares announced by Shareholders Foundation	16/02/22	PR
INSTADOSE PHARMA CORP. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	19/01/22	AQ
Instadose US Announces Management Transition	14/01/22	AQ
Instadose US Announces Management Transition	14/01/22	PR
INSTADOSE PHARMA CORP. : Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits, Unregistered Sale of Equity Securities, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Change in Shell Company Status, Other Events (form 8-K)	07/01/22	AQ
Instadose Pharma Corp Ships 2.125 Metric Tons - Largest International Cannabis Delivery in History	05/01/22	PR
North Macedonia a critical part of Instadose’s plans to become world’s largest medical cannabis supplier	10/12/21	AQ
INSTADOSE PHARMA CORP. : Other Events, Financial Statements and Exhibits (form 8-K)	24/11/21	AQ
INSTADOSE PHARMA CORP. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	21/10/21	AQ
Mikrocoze : INSTADOSE PHARMA CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	13/10/21	AQ
INSTADOSE PHARMA CORP. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	22/09/21	AQ
INSTADOSE PHARMA : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	14/07/21	AQ
INSTADOSE PHARMA CORP. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	15/06/21	AQ
INSTADOSE PHARMA CORP. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	06/05/21	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Instadose Pharma Corp.

Actions

INSD

US45783B1035

Communiqués

Filtres